Calpain Inhibitor I, ALLN

Details for Product No. ABIN629157, Supplier: Log in to see
Application
Blocking Reagent (BR), Inhibition Assay (InhA)
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Available images

Purpose A Calpain inhibitor
Sequence Ac-Leu-Leu-Nile-CHO
Characteristics A cell-permeable inhibitor of calpain I (Ki = 190 nM), calpain II (Ki = 220 nM), cathepsin B (Ki = 150 nM), and cathepsin L (Ki = 0.5 nM). Inhibits neutral cysteine proteases and the proteasome (Ki = 6 µM). Can initiate apoptosis in HL-60 cells but blocks dexamethasone-induced apoptosis in thymocytes and cycloheximide-induced apoptosis in metamyelocytes. Inhibits cyclin B degradation and arrests the cell cycle at G1/S and at meta-/anaphase.
Purity ≥ 95 % by HPLC
Chemical Name Ac-LLnL-CHO, MG-101, N-Acetyl-L-leucyl-L-leucyl-L-norleucinal, N-Acetyl-Leu-Leu-Nle-al
Formula C₂₀H₃₇N₃O₄
Permeability Cell-permeable
Solubility DMSO (25 mg/ml) or EtOH
Molecular Weight 383.54 g/mol
CAS-No 110044-82-1
Research Area Kinases/Phosphatases
Restrictions For Research Use only
Format Powder
Handling Advice Protect from moisture and air
Storage -20 °C
Expiry Date 24 months
Supplier Images
 image for Calpain Inhibitor I, ALLN (ABIN629157) Calpain Inhibitor I, ALLN
Product cited in: Cho, Yoon, Kim, Woo, Rhee: "Circadian rhythm of hyperoxidized peroxiredoxin II is determined by hemoglobin autoxidation and the 20S proteasome in red blood cells." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, Issue 33, pp. 12043-8, 2014 (PubMed).